Cardiff Oncology Inc. Recorded Big Gain
Tue, Aug 08, 2023 at 07:41 PM
Cardiff Oncology Inc. (CRDF:NASDAQ) soared at $2.18, representing a gain of 38.9%. On Tue, Aug 08, 2023, CRDF:NASDAQ hit a New 2-Week High of $2.18. The stock got featured on our News Catalysts scanner on Mon, Aug 07, 2023 at 06:10 PM in the 'BIOTECH' category. From Tue, Jul 25, 2023, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Tue, Aug 08, 2023 at $2.79 with a volume of 21M+.
About Cardiff Oncology Inc. (CRDF:NASDAQ)
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic...
Top 10 Gainers:
- Bruush Oral Care Inc. (BRSH:NASDAQ), 139.13%
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 53.22%
- Infinity Pharmaceuticals, Inc. (INFI:NASDAQ), 45.88%
- IronNet Inc. (IRNT:NYSE), 41.67%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 38.85%
- Tilray, Inc. (TLRY:NASDAQ), 36.04%
- Signature Bank (SBNY:NASDAQ), 33.33%
- VeriFone Systems, Inc. (PAY:NYSE), 31.22%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 29.5%
- Fresh2 Group Ltd Sponsored ADR (New) (FRES:NASDAQ), 29.41%